Advanced search
Publication Cover
British Journal of Neurosurgery Volume 18, 2004 - Issue 5
Submit an article Journal homepage
57
Views
71
CrossRef citations to date
0
Altmetric
Research Article

Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up

HB Newton Division of Neuro-Oncology, Dardinger Neuro-Oncology Center, Department of Neurology Ohio State University Medical Center & James Cancer Hospital and Solove Research Institute Columbus Ohio USA
,
SR Scott Division of Neuro-Oncology, Dardinger Neuro-Oncology Center, Department of Neurology Ohio State University Medical Center & James Cancer Hospital and Solove Research Institute Columbus Ohio USA
&
C Volpi Division of Neuro-Oncology, Dardinger Neuro-Oncology Center, Department of Neurology Ohio State University Medical Center & James Cancer Hospital and Solove Research Institute Columbus Ohio USA
Pages 495-499 | Published online: 20 Aug 2009

Citations (71)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

E. Le Rhun, S. Taillibert & M. C. Chamberlain. (2016) Systemic therapy for recurrent meningioma. Expert Review of Neurotherapeutics 16:8, pages 889-901.
Read now
Marc C Chamberlain. (2013) Is there effective systemic therapy for recurrent surgery-and radiation-refractory meningioma?. CNS Oncology 2:1, pages 1-5.
Read now
Marc C Chamberlain & Jill S Barnholtz-Sloan. (2011) Medical treatment of recurrent meningiomas. Expert Review of Neurotherapeutics 11:10, pages 1425-1432.
Read now
Patrick Y Wen & Jan Drappatz. (2006) Novel therapies for meningiomas. Expert Review of Neurotherapeutics 6:10, pages 1447-1464.
Read now

Articles from other publishers (67)

Ritanksha Joshi, Anuja Sharma & Ritu Kulshreshtha. (2024) Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma. Molecular Therapy: Oncology 32:1, pages 200782.
Crossref
Swati Sharma, Rashmi Rana, Prem Prakash & Nirmal Kumar Ganguly. (2023) Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors. Molecular and Cellular Biochemistry 479:1, pages 127-170.
Crossref
Ataollah Shahbandi, Darsh S. Shah, Caroline C. Hadley & Akash J. Patel. (2023) The Role of Pharmacotherapy in Treatment of Meningioma: A Systematic Review. Cancers 15:2, pages 483.
Crossref
A. Yohan Alexander, Chiduziem Onyedimma, Archis R. Bhandarkar, Yagiz U. Yolcu, Giorgos D. Michalopoulos, Mohamad Bydon & Michael J. Link. (2022) The role of bevacizumab for treatment-refractory intracranial meningiomas: a single institution’s experience and a systematic review of the literature. Acta Neurochirurgica 164:11, pages 3011-3023.
Crossref
Juan Esteban Garcia-Robledo, Camila Ordóñez-Reyes, Alejandro Ruiz-Patiño, Álvaro Muñoz, Oscar Arrieta, Enrique Jiménez, Fernando Hakim, Diego Gómez, Juan Fernando Ramón & Andrés F. Cardona. 2022. Brain Tumors. Brain Tumors.
Abdalrahman Nassar & Volodymyr Smolanka. (2022) Оновлена інформація про менінгіоми крила клиноподібної кістки. INTERNATIONAL NEUROLOGICAL JOURNAL 18:1, pages 43-48.
Crossref
Thomas Graillon, Emeline Tabouret & Olivier Chinot. (2021) Chemotherapy and targeted therapies for meningiomas: what is the evidence?. Current Opinion in Neurology 34:6, pages 857-867.
Crossref
Tamara Ius, Alessandro Tel, Giuseppe Minniti, Teresa Somma, Domenico Solari, Michele Longhi, Pasquale De Bonis, Alba Scerrati, Mario Caccese, Valeria Barresi, Alba Fiorentino, Leonardo Gorgoglione, Giuseppe Lombardi & Massimo Robiony. (2021) Advances in Multidisciplinary Management of Skull Base Meningiomas. Cancers 13:11, pages 2664.
Crossref
Elena Solli & Roger E. Turbin. (2021) Primary and Secondary Optic Nerve Sheath Meningioma. Journal of Neurological Surgery Part B: Skull Base 82:01, pages 027-071.
Crossref
Mario Caccese, Vittorina Zagonel & Giuseppe Lombardi. 2021. Stereotactic Radiosurgery for the Treatment of Central Nervous System Meningiomas. Stereotactic Radiosurgery for the Treatment of Central Nervous System Meningiomas 33 35 .
Taylor Anne Wilson, Lei Huang, Dinesh Ramanathan, Miguel Lopez-Gonzalez, Promod Pillai, Kenneth De Los Reyes, Muhammad Kumal & Warren Boling. (2020) Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management. Frontiers in Oncology 10.
Crossref
Oriol Mirallas, David Marmolejo, Augusto Valdivia & Maria Vieito. (2020) Grade I meningioma with disseminated bone disease: a rare clinical phenomenon. BMJ Case Reports 13:4, pages e233708.
Crossref
Haroon Ahmad & David Schiff. (2019) Multimodality Therapy of Patients with Refractory Meningiomas. Current Treatment Options in Oncology 20:6.
Crossref
E. Schorb & C. F. Waller. 2019. Tumor Angiogenesis. Tumor Angiogenesis 609 625 .
Fares Nigim, Hiroaki Wakimoto, Ekkehard Kasper, Linda Ackermans & Yasin Temel. (2018) Emerging Medical Treatments for Meningioma in the Molecular Era. Biomedicines 6:3, pages 86.
Crossref
Justin T. Jordan & Scott R. Plotkin. (2018) Benign Intracranial Tumors. Neurologic Clinics 36:3, pages 501-516.
Crossref
Saksham Gupta, Wenya Linda Bi & Ian F. Dunn. (2018) Medical management of meningioma in the era of precision medicine. Neurosurgical Focus 44:4, pages E3.
Crossref
Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 513 525 .
E. Schorb & C. F. Waller. 2018. Tumor Angiogenesis. Tumor Angiogenesis 1 18 .
E. Schorb & C. F. Waller. 2017. Tumor Angiogenesis. Tumor Angiogenesis 1 18 .
Jungook KimKyu Hong KimYoung Zoon Kim. (2017) The Clinical Outcome of Hydroxyurea Chemotherapy after Incomplete Resection of Atypical Meningiomas. Brain Tumor Research and Treatment 5:2, pages 77.
Crossref
Iddo Paldor, Mohammed Awad, Yuval Z. Sufaro, Andrew H. Kaye & Yigal Shoshan. (2016) Review of controversies in management of non-benign meningioma. Journal of Clinical Neuroscience 31, pages 37-46.
Crossref
Michael Karsy, Nguyen Hoang, Talmadge Barth, Lindsay Burt, William Dunson, David L. Gillespie & Randy L. Jensen. (2016) Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies. World Neurosurgery 86, pages 210-219.
Crossref
Elena Mazza, Alba Brandes, Silvia Zanon, Marika Eoli, Giuseppe Lombardi, Marina Faedi, Enrico Franceschi & Michele Reni. (2015) Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Cancer Chemotherapy and Pharmacology 77:1, pages 115-120.
Crossref
Taohui Ouyang, Na Zhang, Long Wang, Zheng Li & Jian Chen. (2015) Sphenoid wing meningiomas: Surgical strategies and evaluation of prognostic factors influencing clinical outcomes. Clinical Neurology and Neurosurgery 134, pages 85-90.
Crossref
Annette Wilisch-Neumann, Doreen Pachow, Maren Wallesch, Astrid Petermann, Frank D. Böhmer, Elmar Kirches & Christian Mawrin. (2014) Re-evaluation of cytostatic therapies for meningiomas in vitro. Journal of Cancer Research and Clinical Oncology 140:8, pages 1343-1352.
Crossref
Jeffrey J. Raizer, Sean A. Grimm, Alfred Rademaker, James P. Chandler, Kenji Muro, Irene Helenowski, Laurie Rice, Katie McCarthy, Sandra K. Johnston, Maciej M. Mrugala & Marc Chamberlain. (2014) A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas. Journal of Neuro-Oncology 117:1, pages 93-101.
Crossref
Alan A. MoazzamNaveed Wagle & Gabriel Zada. (2013) Recent developments in chemotherapy for meningiomas: a review. Neurosurgical Focus 35:6, pages E18.
Crossref
Marc C. Chamberlain. (2012) The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma. Current Opinion in Oncology 24:6, pages 666-671.
Crossref
Christine Marosi. (2012) Drug therapy for recurrent, progressive, atypical, and malignant meningiomas. memo - Magazine of European Medical Oncology 5:3, pages 218-222.
Crossref
Emil Lou, Ashley L. Sumrall, Scott Turner, Katherine B. Peters, Annick Desjardins, James J. Vredenburgh, Roger E. McLendon, James E. HerndonIIII, Frances McSherry, Julie Norfleet, Henry S. Friedman & David A. Reardon. (2012) Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series. Journal of Neuro-Oncology 109:1, pages 63-70.
Crossref
Marc C. Chamberlain. (2011) Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma. Journal of Neuro-Oncology 107:2, pages 315-321.
Crossref
Min-Su KimDong-Woo YuYoung-Jin JungSang Woo KimChul-Hoon ChangOh-Lyong Kim. (2012) Long-Term Follow-Up Result of Hydroxyurea Chemotherapy for Recurrent Meningiomas. Journal of Korean Neurosurgical Society 52:6, pages 517.
Crossref
Manmeet S. Ahluwalia. 2012. Schmidek and Sweet Operative Neurosurgical Techniques. Schmidek and Sweet Operative Neurosurgical Techniques 94 104 .
Albert H. Kim, Lance S. Governale, Dong H. Kim & Peter M. Black. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II 657 664 .
David A. Reardon, Andrew D. Norden, Annick Desjardins, James J. Vredenburgh, James E. HerndonIIII, April Coan, John H. Sampson, Sridharan Gururangan, Katherine B. Peters, Roger E. McLendon, Julie A. Norfleet, Eric S. Lipp, Jan Drappatz, Patrick Y. Wen & Henry S. Friedman. (2011) Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma. Journal of Neuro-Oncology 106:2, pages 409-415.
Crossref
Santosh Saraf, Bridget J. McCarthy & J. Lee Villano. (2011) Update on Meningiomas. The Oncologist 16:11, pages 1604-1613.
Crossref
Zanetta Lamar & Glenn J. Lesser. (2011) Management of Meningeal Neoplasms: Meningiomas and Hemangiopericytomas. Current Treatment Options in Oncology 12:3, pages 230-239.
Crossref
Marc C. Chamberlain & Sandra K. Johnston. (2011) Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series. Journal of Neuro-Oncology 104:3, pages 765-771.
Crossref
R. J. Naylor, B. Dunkel, S. Dyson, M. P. Paz‐Penuelas & J. Dobson. (2010) A retrobulbar meningioma as a cause of unilateral exophthalmos and blindness in a horse. Equine Veterinary Education 22:10, pages 503-510.
Crossref
Patrick Y. Wen, Eudocia Quant, Jan Drappatz, Rameen Beroukhim & Andrew D. Norden. (2010) Medical therapies for meningiomas. Journal of Neuro-Oncology 99:3, pages 365-378.
Crossref
Jeffrey Raizer. (2010) Meningiomas. Current Treatment Options in Neurology 12:4, pages 360-368.
Crossref
George A. Alexiou, Pinelopi Gogou, Sofia Markoula & Athanasios P. Kyritsis. (2010) Management of meningiomas. Clinical Neurology and Neurosurgery 112:3, pages 177-182.
Crossref
Brian J. Goldsmith, Michael W. McDermott & Susan M. Chang. 2010. Leibel and Phillips Textbook of Radiation Oncology. Leibel and Phillips Textbook of Radiation Oncology 446 460 .
Andrew D. Norden & Patrick Y. Wen. 2010. Meningiomas. Meningiomas 667 679 .
Felix Umansky, Siegal Sadetzki, Sergey Spektor, Guy Rosenthal, Shifra Fraifeld & Yigal Shoshan. 2010. Meningiomas. Meningiomas 79 97 .
Andrew D. Norden, Jeffrey J. Raizer, Lauren E. Abrey, Kathleen R. Lamborn, Andrew B. Lassman, Susan M. Chang, W. K. Alfred Yung, Mark R. Gilbert, Howard A. Fine, Minesh Mehta, Lisa M. DeAngelis, Timothy F. Cloughesy, H. Ian Robins, Kenneth Aldape, Janet Dancey, Michael D. Prados, Frank Lieberman & Patrick Y. Wen. (2009) Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. Journal of Neuro-Oncology 96:2, pages 211-217.
Crossref
Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn, Andrew D. Norden, Timothy F. Cloughesy, Lauren E. Abrey, Howard A. Fine, Susan M. Chang, H. Ian Robins, Karen Fink, Lisa M. DeAngelis, Minesh Mehta, Emmanuelle Di Tomaso, Jan Drappatz, Santosh Kesari, Keith L. Ligon, Ken Aldape, Rakesh K. Jain, Charles D. Stiles, Merrill J. Egorin & Michael D. Prados. (2009) Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro-Oncology 11:6, pages 853-860.
Crossref
Kawai J. Kuong & Andrei Kuzminov. (2009) Cyanide, Peroxide and Nitric Oxide Formation in Solutions of Hydroxyurea Causes Cellular Toxicity and May Contribute to Its Therapeutic Potency. Journal of Molecular Biology 390:5, pages 845-862.
Crossref
Michael T. Walsh & William T. Couldwell. (2009) Management options for cavernous sinus meningiomas. Journal of Neuro-Oncology 92:3, pages 307-316.
Crossref
Chrissa Sioka & Athanassios P. Kyritsis. (2008) Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas. Journal of Neuro-Oncology 92:1, pages 1-6.
Crossref
Glen H. J. Stevens & David M. Peereboom. 2009. Meningiomas. Meningiomas 293 298 .
Christine Marosi, Marco Hassler, Karl Roessler, Michele Reni, Milena Sant, Elena Mazza & Charles Vecht. (2008) Meningioma. Critical Reviews in Oncology/Hematology 67:2, pages 153-171.
Crossref
Sean Grimm & Jeffrey J. Raizer. (2008) Meningiomas. Current Treatment Options in Neurology 10:4, pages 315-320.
Crossref
Felix Umansky, Yigal Shoshan, Guy Rosenthal, Shifra Fraifeld & Sergey Spektor. (2008) Radiation-induced meningioma. Neurosurgical Focus 24:5, pages E7.
Crossref
Mahlon D. Johnson, Burak Sade, Michael T. Milano, Joung H. Lee & Steven A. Toms. (2007) New prospects for management and treatment of inoperable and recurrent skull base meningiomas. Journal of Neuro-Oncology 86:1, pages 109-122.
Crossref
Steven Grunberg. 2008. Principles and Practice of Stereotactic Radiosurgery. Principles and Practice of Stereotactic Radiosurgery 271 273 .
Vinay Gupta, Christian G. Samuleson, Susan Su & Thomas C. Chen. (2007) Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition. Neurosurgical Focus 23:4, pages E9.
Crossref
Andrew D. Norden, Jan Drappatz & Patrick Y. Wen. (2007) Targeted drug therapy for meningiomas. Neurosurgical Focus 23:4, pages E12.
Crossref
Herbert B. Newton. (2007) Hydroxyurea chemotherapy in the treatment of meningiomas. Neurosurgical Focus 23:4, pages E11.
Crossref
Brian T. Ragel, William T. Couldwell, Robert D. Wurster & Randy L. Jensen. (2007) Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas. Neurosurgical Focus 23:4, pages E10.
Crossref
Theresa G. Cargioli, Hasan C. Ugur, Naren Ramakrishna, Jennifer Chan, Peter M. Black & Rona S. Carroll. (2007) ESTABLISHMENT OF AN IN VIVO MENINGIOMA MODEL WITH HUMAN TELOMERASE REVERSE TRANSCRIPTASE. Neurosurgery 60:4, pages 750-760.
Crossref
Vinay GuptaYuzhuang S. SuChristian G. SamuelsonLeonard F. Liebes, Marc C. Chamberlain, Florence M. HofmanAxel H. Schönthal & Thomas C. Chen. (2007) Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas. Journal of Neurosurgery 106:3, pages 455-462.
Crossref
Brian T. Ragel, David L. Gillespie, Vitaly Kushnir, Nika Polevaya, David Kelly & Randy L. Jensen. (2006) CALCIUM CHANNEL ANTAGONISTS AUGMENT HYDROXYUREA- AND RU486-INDUCED INHIBITION OF MENINGIOMA GROWTH IN VIVO AND IN VITRO. Neurosurgery 59:5, pages 1109-1121.
Crossref
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy 463 474 .
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy 21 43 .
Carsten Nieder & Mark R. Gilbert. 2006. Multimodal Concepts for Integration of Cytotoxic Drugs. Multimodal Concepts for Integration of Cytotoxic Drugs 165 186 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.